Search Results for 'Regenerative medicine'

NUI Galway researchers are part of an exciting EU-funded project looking at how stem cells from adult fat tissue could be used to activate the regeneration of cartilage. If successful, their work could lead to effective new treatments for millions of osteoarthritis sufferers. Positive, early results indicate the treatment could become a reality for patients within the next five years.

REMEDI, The Regenerative Medicine Institute at NUI Galway and Orbsen Therapeutics have entered into an agreement with Cardium Therapeutics to utilise Cardium’s Excellagen® pharmaceutically-formulated gel as a delivery agent for Orbsen Therapeutics’ proprietary stromal cell therapy in pre-clinical studies for the potential treatment of diabetic foot ulcers.

Ireland has the capacity to be an international centre for commercialisation in the field of regenerative medicine, delegates at an international stem cell conference in NUI Galway heard this week.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

NUI Galway is to link up with two leading Chinese universities to further research and facilitate student and researcher exchanges between Galway and China.

Director of REMEDI, Professor Timothy O’Brien, is Head of Medicine at NUI Galway and a consultant endocrinologist at Galway University Hospital. REMEDI is one of Ireland’s top biomedical research institutes.

In a major boost for regenerative medicine research in Ireland, Minister for Enterprise, Trade, and Innovation, Batt O’Keeffe announced this week the funding of almost €10 million for the Regenerative Medicine Institute (REMEDI) at NUI Galway.

A €3.5 million EU funded collaborative research project aimed at revolutionising the processing of high quality adult stem cells has been launched at NUI Galway.